Progressive Care Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q3 FY2012 As of Sep 30, 2012	Q2 FY2012 As of Jun 30, 2012	Q1 FY2012 As of Mar 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q3 FY2011 As of Sep 30, 2011	Q2 FY2011 As of Jun 30, 2011
Current Assets
Cash
Accounts receivable – trade, net
Income tax receivable
Receivables - other
Receivables - other, net
Inventory, net
Prepaid expenses
Total Current Assets
Property and equipment, net
Debt issue costs - net

Other Assets
Goodwill
Intangible assets, net
Right of use assets, net
Operating right-of-use assets, net
Finance right-of-use assets, net
Total right of use assets, net
Deposits
Deferred tax asset
Total Other Assets
Total Assets

Current Liabilities
Cash overdraft
Accounts payable and accrued liabilities
Deferred rent payable
Income taxes payable
Notes payable
Debt - related party
Accrued interest payable - related party
Deferred tax liability
Derivative liability
Lease liabilities - current portion
Operating lease liabilities
Finance lease liabilities
Total lease liabilities - current portion
Total Current Liabilities

Long-term Liabilities
Debt
Notes payable and accrued interest, net of current portion
Notes payable, net of current portion
Derivative liabilities
Lease liabilities - net of current portion
Operating lease liabilities, net of current portion
Finance lease liabilities, net of current portion
Total lease liabilities - net of current portion
Total Liabilities
Commitments and Contingencies

Stockholders’ Equity
Preferred Stock
Common stock ($0.0001 par value, 100,000,000 shares authorized; 6,240,731 and 6,222,781 issued and outstanding as of June 30, 2024 and December 31, 2023, respectively)
Additional paid-in capital
Accumulated deficit
Total Stockholders' Equity
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Comments